Affiliation: | a UPRES EA 1085, Biomolécules et Cibles Cellulaires Tumorales – Proliferation Cellulaire et Inhibition Enzymatique, Laboratoire de Biochimie, Faculté de Pharmacie, 2 Rue du Dr. Marcland, 87025 Limoges Cédex, France b INSERM U439, Pathologie Moléculaire des Récepteurs Nucléaires, 70 Rue de Navacelles, 34090 Montpellier, France |
Abstract: | The interaction between the estrogen receptor and a variety of flavonoids was studied in the presence or absence of estradiol using a stably-transfected human breast cancer cell line (MVLN). On the other hand, flavonoids were evaluated for their effects on proliferation in estrogen-dependent (MCF-7) and independent (MDA-MB231) human breast cancer cells. We established a relationship structure-activity and determined regions and/or substituents essential for estrogenic or antiestrogenic activities. In contrast, we did not find the same relationship for cell proliferation. Among all flavonoids used, only 7-methoxyflavanone and 7,8-dihydroxyflavone at high concentrations (50 μM) possess antiestrogenic and antiproliferative activities. These results suggest that two hydroxyls (in positions 7 and 8) or 7-methoxy substituents are essential for the antiestrogenic activity of flavonoids. However, it seems that flavonoids at high concentrations exert their antiproliferative activity through other estrogen receptor-independent mechanisms. |